Abstract
The goal of this chapter is to introduce the main metabolites of proton MRS with emphasis on developmental changes. Understanding how normal metabolite levels may change in the developing brain is important for the interpretation of MR spectra obtained from children.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Huppi PS. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2002;48(6):949–58.
van der Knaap MS, van der Grond J, van Rijen PC, Faber JA, Valk J, Willemse K. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology. 1990;176(2):509–15.
Huppi PS, Posse S, Lazeyras F, Burri R, Bossi E, Herschkowitz N. Magnetic resonance in preterm and term newborns: 1H-spectroscopy in developing human brain. Pediatr Res. 1991;30(6):574–8.
Toft PB, Leth H, Lou HC, Pryds O, Henriksen O. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J Magn Reson Imaging. 1994;4(5):674–80.
Cady EB, Penrice J, Amess PN, et al. Lactate, N-acetylaspartate, choline and creatine concentrations, and spin-spin relaxation in thalamic and occipito-parietal regions of developing human brain. Magn Reson Med. 1996;36(6):878–86.
Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med. 1993;30(4):424–37.
Pouwels PJ, Brockmann K, Kruse B, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res. 1999;46(4):474–85.
Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol. 1995;16(2):233–9.
Nanto-Salonen K, Komu M, Lundbom N, et al. Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology. 1999;53(2):303–7.
Ross BD, Danielsen ER, Bluml S. Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis. 1996;14 Suppl 1:30–9.
Smart JL, Dobbing J, Adlard BP, Lynch A, Sands J. Vulnerability of developing brain: relative effects of growth restriction during the fetal and suckling periods on behavior and brain composition of adult rats. J Nutr. 1973;103(9):1327–38.
Lentner C. Geigy scientific tables. In: Ciba G, editor. Units of measurement body fluids nutrition, vol. 1. Ciba-Geigy: Basel, Switzerland; 1981. p. 220. 222, 223.
Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson. 1993;102:1–8.
Tallan HH. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem. 1957;224(1):41–5.
Baslow MH. Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J Neurochem. 2000;75(2):453–9.
Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson. 1993;102:9–19.
Brooks WM, Stidley CA, Petropoulos H, et al. Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. J Neurotrauma. 2000;17(8):629–40.
Gasparovic C, Arfai N, Smid N, Feeney DM. Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury. J Neurotrauma. 2001;18(3):241–6.
Schuhmann MU, Stiller D, Skardelly M, Thomas S, Samii M, Brinker T. Long-time in-vivo metabolic monitoring following experimental brain contusion using proton magnetic resonance spectroscopy. Acta Neurochir Suppl. 2002;81:209–12.
Bluml S, Seymour KJ, Ross BD. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magn Reson Med. 1999;42(4):643–54.
Lien YH, Shapiro JI, Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest. 1990;85(5):1427–35.
Panigrahy A, Krieger MD, Gonzalez-Gomez I, et al. Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol. 2006;27(3):560–72.
Videen JS. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. [see comments.]. J Clin Investig. 1995;95(2):788–93.
Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR: Am J Neuroradiol. 1999;20(9):1619–27.
Kruse B, Hanefeld F, Christen HJ, et al. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J Neurol. 1993;241(2):68–74.
Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6):672–9.
Daikhin Y, Yudkoff M. Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr. 2000;130(4S Suppl):1026S–31S.
Erecinska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol. 1990;35(4):245–96.
Kreis R. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. [see comments.]. Radiology. 1992;182(1):19–27.
Flint AC, Liu X, Kriegstein AR. Nonsynaptic glycine receptor activation during early neocortical development. Neuron. 1998;20(1):43–53.
Kovanlikaya A, Panigrahy A, Krieger M, et al. Untreated pediatric primitive neuroectodermal tumor in vivo: quantitation of taurine with MR spectroscopy. Radiology. 2005;236(3):1020–5.
Moreno-Torres A, Martinez-Perez I, Baquero M, et al. Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: Contribution to noninvasive differential diagnosis with cerebellar astrocytomas. Neurosurgery. 2004;55:824–9.
Ross BD, Ernst T, Kreis R, et al. 1H MRS in acute traumatic brain injury. J Magn Reson Imaging. 1998;8(4):829–40.
Holshouser BA, Ashwal S, Luh GY, et al. Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children. Radiology. 1997;202(2):487–96.
Holshouser BA, Ashwal S, Shu S, Hinshaw Jr DB. Proton MR spectroscopy in children with acute brain injury: comparison of short and long echo time acquisitions. J Magn Reson Imaging. 2000;11(1):9–19.
Haseler LJ, Arcinue E, Danielsen ER, Bluml S, Ross BD. Evidence from proton magnetic resonance spectroscopy for a metabolic cascade of neuronal damage in shaken baby syndrome. Pediatrics. 1997;99(1):4–14.
Condon B, Oluoch-Olunya D, Hadley D, Teasdale G, Wagstaff A. Early 1H magnetic resonance spectroscopy of acute head injury: four cases. J Neurotrauma. 1998;15(8):563–71.
Seymour ZA, Panigrahy A, Finlay JL, Nelson Jr MD, Bluml S. Citrate in pediatric CNS tumors? AJNR Am J Neuroradiol. 2008;29(5):1006–11.
Costello LC, Franklin RB, Narayan P. Citrate in the diagnosis of prostate cancer. Prostate. 1999;38(3):237–45.
Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr. 1990;14(4):497–504.
Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2003;49(2):223–32.
Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000;13(3):129–53.
Davies NP, Wilson M, Natarajan K, et al. Non-invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in-vivo 1H MRS at 1.5 tesla confirmed by ex-vivo high-resolution magic-angle spinning NMR. NMR Biomed. 2010;23(1):80–7.
Carapella CM, Carpinelli G, Knijn A, Raus L, Caroli F, Podo F. Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours. Acta Neurochir Suppl. 1997;68:127–32.
Lehnhardt FG, Röhn G, Ernestus RI, Grüne M, Hoehn M. 1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components. NMR Biomed. 2001;14(5):307–17.
Lehnhardt FG, Bock C, Röhn G, Ernestus RI, Hoehn M. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed. 2005;18(6):371–82.
Seymour KJ, Bluml S, Sutherling J, Sutherling W, Ross BD. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. Magma. 1999;8(1):33–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Blüml, S. (2013). Metabolites of Proton Magnetic Resonance Spectroscopy and Normal Age-Dependent Changes. In: Blüml, S., Panigrahy, A. (eds) MR Spectroscopy of Pediatric Brain Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5864-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5864-8_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5863-1
Online ISBN: 978-1-4419-5864-8
eBook Packages: MedicineMedicine (R0)